First results of the EORTC-GELA H9 randomized trials:: The H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable or unfavorable early stage Hodgkin's lymphoma (HL).

被引：39

作者：

Noordijk, EM

Thomas, J

Fermé, C

Van 't Veer, MB

Brice, P

Diviné, M

Morschhauser, F

Carde, P

Eghbali, H

Henry-Amar, M

机构：

[1] Leiden Univ, Med Ctr, Leiden, Netherlands

[2] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

[3] Inst Gustave Roussy, Villejuif, France

[4] Erasmus Med Ctr, Rotterdam, Netherlands

[5] Hop St Louis, Paris, France

[6] Hop Henri Mondor, F-94010 Creteil, France

[7] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France

[8] Inst Bergonie, Bordeaux, France

[9] Ctr Reg Francois Baclesse, Caen, France

来源：

关键词：

D O I：

10.1200/jco.2005.23.16_suppl.6505

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：561S / 561S

页数：1